Evidence map›Paper›PMID 41100032›Full record

ArticleJournal of cardiovascular translational research2025

Role of N,N,N Trimethyl-L-alanyl-L-proline Betaine Levels in the Process of Myocardial Infarction.

Ziyang Wu, Dong Wang, Chengchun Tang

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cardiovascular translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ziyang WuDepartment of Cardiology, School of Medicine, Southeast University, Zhongda Hospital, Dingjiaqiao 87, Gulou District, Nanjing, 210009, Jiangsu, China.
Dong WangDepartment of Cardiology, School of Medicine, Southeast University, Zhongda Hospital, Dingjiaqiao 87, Gulou District, Nanjing, 210009, Jiangsu, China. wangdong_seu@163.com.
Chengchun TangDepartment of Cardiology, School of Medicine, Southeast University, Zhongda Hospital, Dingjiaqiao 87, Gulou District, Nanjing, 210009, Jiangsu, China.

Funding

Jiangsu Provincial Medical Key Discipline (Laboratory) ZDXK202207National Natural Science Foundation of China 82170433
6 · The paper itself

Abstract

The aim of this study was to evaluate the relationship between N,N,N trimethyl-L-alanyl-L-proline betaine (TMAP) levels and myocardial infarction (MI). Causal relationship was estimated based on TMAP levels and MI data from genome-wide association studies (GWAS). The main analysis method of bidirectional two-sample Mendelian randomization (TSMR) was inverse variance weighting (IVW), with four other supplementary methods used. The IVW method yielded results indicating a negative correlation between TMAP levels and MI (IVW, odds ratio [OR] = 0.976, 95% confidence interval [CI]: 0.960-0.992, P = 0.004). In contrast, the inverse analysis did not provide evidence that MI affects TMAP levels (P > 0.05). This study provided evidence for the causal effect of TMAP levels on MI. It was not the case in the opposite situation. It is plausible that TMAP may serve as a protective factor in MI.

Indexed as

DipeptidesMyocardial InfarctionBiomarkersGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMendelian Randomization AnalysisPhenotypeProtective FactorsRisk AssessmentRisk FactorsBiomarkersDipeptidesCoronary heart diseaseMetabolicTwo-sample Mendelian randomization

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.